USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.22−0.35 (-2.58%)
Close on Nov 18, 2026Market cap $244.26MP/E –Yield –
USANA Health Sciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
USANA Health Sciences's operating income for the twelve months ending Jul 4, 2026 was -$1.08M, down 101.9% year over year. For fiscal 2025 it was $37.43M, down 43.6% from the year before. Over ten years it grew -12.5% a year on average. The highest annual figure on record is $188.35M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $37.43M | -43.6% |
| FY2024 | Dec 28, 2024 | $66.32M | -28.7% |
| FY2023 | Dec 30, 2023 | $93.07M | -13.5% |
| FY2022 | Dec 31, 2022 | $107.61M | -36.8% |
| FY2021 | Jan 1, 2022 | $170.19M | -3.6% |
| FY2020 | Jan 2, 2021 | $176.49M | +20.7% |
| FY2019 | Dec 28, 2019 | $146.19M | -22.4% |
| FY2018 | Dec 29, 2018 | $188.35M | +42.1% |
| FY2017 | Dec 30, 2017 | $132.50M | -4.4% |
| FY2016 | Dec 31, 2016 | $138.62M | -2.1% |
| FY2015 | Jan 2, 2016 | $141.66M | +22.0% |
| FY2014 | Jan 3, 2015 | $116.10M | -0.5% |
| FY2013 | Dec 28, 2013 | $116.71M | +18.9% |
| FY2012 | Dec 29, 2012 | $98.18M | +27.1% |
| FY2011 | Dec 31, 2011 | $77.26M | +13.3% |
| FY2010 | Jan 1, 2011 | $68.22M | +34.3% |
| FY2009 | Jan 2, 2010 | $50.79M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 4, 2026 | -$20.00M | -219.6% |
| Q1 FY2026 | Apr 4, 2026 | $13.87M | -11.5% |
| Q4 FY2025 | Jan 3, 2026 | $3.82M | -53.5% |
| Q3 FY2025 | Sep 27, 2025 | $1.22M | -92.2% |
| Q2 FY2025 | Jun 28, 2025 | $16.72M | -6.3% |
| Q1 FY2025 | Mar 29, 2025 | $15.67M | -36.5% |
| Q4 FY2024 | Dec 28, 2024 | $8.21M | -66.1% |
| Q3 FY2024 | Sep 28, 2024 | $15.60M | -11.4% |
| Q2 FY2024 | Jun 29, 2024 | $17.84M | -26.9% |
| Q1 FY2024 | Mar 30, 2024 | $24.67M | -8.1% |
| Q4 FY2023 | Dec 30, 2023 | $24.22M | +7.4% |
| Q3 FY2023 | Sep 30, 2023 | $17.61M | -22.2% |
| Q2 FY2023 | Jul 1, 2023 | $24.40M | -16.9% |
| Q1 FY2023 | Apr 1, 2023 | $26.85M | -18.8% |
| Q4 FY2022 | Dec 31, 2022 | $22.55M | -28.4% |
| Q3 FY2022 | Oct 1, 2022 | $22.63M | -44.5% |
| Q2 FY2022 | Jul 2, 2022 | $29.37M | -45.3% |
| Q1 FY2022 | Apr 2, 2022 | $33.07M | -25.2% |
| Q4 FY2021 | Jan 1, 2022 | $31.51M | -40.0% |
| Q3 FY2021 | Oct 2, 2021 | $40.77M | -10.1% |
| Q2 FY2021 | Jul 3, 2021 | $53.72M | +35.7% |
| Q1 FY2021 | Apr 3, 2021 | $44.20M | +13.3% |
| Q4 FY2020 | Jan 2, 2021 | $52.54M | +17.9% |
| Q3 FY2020 | Sep 26, 2020 | $45.36M | +27.9% |
| Q2 FY2020 | Jun 27, 2020 | $39.59M | +27.1% |
| Q1 FY2020 | Mar 28, 2020 | $39.01M | +11.5% |
| Q4 FY2019 | Dec 28, 2019 | $44.57M | -8.2% |
| Q3 FY2019 | Sep 28, 2019 | $35.46M | -22.1% |
| Q2 FY2019 | Jun 29, 2019 | $31.16M | -39.1% |
| Q1 FY2019 | Mar 30, 2019 | $35.00M | -18.8% |
| Q4 FY2018 | Dec 29, 2018 | $48.57M | +35.3% |
| Q3 FY2018 | Sep 29, 2018 | $45.51M | +45.1% |
| Q2 FY2018 | Jun 30, 2018 | $51.14M | +58.0% |
| Q1 FY2018 | Mar 31, 2018 | $43.13M | +31.1% |
| Q4 FY2017 | Dec 30, 2017 | $35.89M | +12.7% |
| Q3 FY2017 | Sep 30, 2017 | $31.36M | -12.5% |
| Q2 FY2017 | Jul 1, 2017 | $32.37M | – |
| Q1 FY2017 | Apr 1, 2017 | $32.89M | – |
| Q4 FY2016 | Dec 31, 2016 | $31.84M | – |
| Q3 FY2016 | Oct 1, 2016 | $35.83M | – |
See a number that looks wrong?